Zentek (CVE:ZEN) Trading 11.5% Higher – Here’s Why

Zentek Ltd. (CVE:ZENGet Free Report)’s share price rose 11.5% on Friday . The company traded as high as C$0.88 and last traded at C$0.87. 124,341 shares changed hands during trading, a decline of 21% from the average session volume of 157,268 shares. The stock had previously closed at C$0.78.

Zentek Stock Performance

The firm has a market cap of C$111.43 million, a P/E ratio of -9.78 and a beta of 0.69. The company has a debt-to-equity ratio of 19.52, a quick ratio of 7.59 and a current ratio of 0.64. The company’s 50 day moving average is C$0.69 and its 200 day moving average is C$0.81.

About Zentek

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada.

Featured Articles

Receive News & Ratings for Zentek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zentek and related companies with MarketBeat.com's FREE daily email newsletter.